Computational Design of New Analogues from Lyngbyastatin-2 against Epidermal Growth Factor Receptor (EGFR) through Molecular Docking

References (21)

1. 1 Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways [DOI]
2. 2 Precursor lesions of ovarian epithelial malignancy [DOI]
3. 3 Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells [DOI]
4. 4 Epithelial ovarian cancer: An overview [DOI]
5. 5 Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges [DOI]
6. 6 Anatomy of enzyme channels [DOI]
7. 7 Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma [DOI]
8. 8 Lyngbyastatins 5–7, Potent Elastase Inhibitors from Floridian Marine Cyanobacteria, Lyngbya spp. [DOI]
9. 9 Lyngbyastatin 4, a Dolastatin 13 Analogue with Elastase and Chymotrypsin Inhibitory Activity from the Marine Cyanobacterium Lyngbya confervoides [DOI]
10. 10 Kempopeptins A and B, Serine Protease Inhibitors with Different Selectivity Profiles from a Marine Cyanobacterium, Lyngbya sp. [DOI]
11. 11 Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer [DOI]
12. 12 Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs [DOI]
13. 13 Epidermal Growth Factor Receptor Expression in Serous Ovarian Carcinoma: An Immunohistochemical Study With Galectin-3 and Cyclin D1 and Outcome [DOI]
14. 14 The emerging role of epidermal growth factor receptor inhibitors in ovarian cancer [DOI]
15. 15 Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment [DOI]
16. 16 Computational cancer biology: education is a natural key to many locks [DOI]
17. 17 Docking Studies reveal Phytochemicals as the long searched Anticancer Drugs for Breast Cancer [DOI]
18. 18 Molecular Modeling and Docking Analysis of CYP1A1 Associated with Head and Neck Cancer to Explore its Binding Regions [DOI]
19. 19 Docking Studies on Anticancer Drugs for Breast Cancer Using Hex
20. 20 Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening [DOI]
21. 21 Synthesis and Anticancer Properties of Novel Truncated Carbocyclic Nucleoside Analogues [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Glycosylated Antibiotics: New Promising Bacterial Efflux Pumps Inhibitors — shares topic coverage
• Integrating In-silico and In-vitro Approaches to Screen the Antidiabetic Drug from Trigonella foenum graecum Linn. — shares topic coverage
• Structural Mapping of Inhibitors Binding Sites on P-glycoprotein: Mechanism of Inhibition of P-Glycoprotein by Herbal Isoflavones — shares topic coverage
• Azamacrocycle Complexes: Synthesis and Xanthine Oxidase and Antioxidant Activity — shares topic coverage
• Evaluation of Selected Natural Compounds for Cancer Stem Cells Targeted Anti-cancer Activity: A Molecular Docking Study — shares topic coverage